» Download Public Reports
13 reports
- Company report
- March 2011
- 5 pages
... Of the benefits of the acquisition this acquisition combines two growing, successful and highly profitable companies, and substantially completes watson S expansion as a leading global generics company ...
December 2010
... With a broader range of customers while servicing pfizer S product portfolio and also help promote its own generic medicine portfolio, thereby optimally utilizing its field force. Australian business Aph ...
January 2012
... To be a leading cutting edge generics company which has resulted in discovery of a value in a scarcity market, because australia is a $12 billion pharmaceutical market and it is extremely difficult for new ...
April 2012
... Of the top 20 medicines will be biologics, while others will be hard-to-develop generics, such as inhalation products. Together, watson and actavis will be well-positioned to be among the leaders ...
November 2012
... As a leading global generics company. The combined company begins operations with a defined global management structure and aggressive integration execution strategies in place to focus on organic growth ...
October 2012
... Of the benefits of the acquisition this acquisition combines two growing, successful and highly profitable companies, and substantially completes watson S expansion as a leading global generics company ...
March 2010
... To work together as partners to promote the objectives of the policy. Members of the generic medicines industry association (gmia) take seriously their responsibility to achieve each of the below objectives ...
September 2009
... New products against already available products and therapies. In this system, prices do not operate effectively as incentives for consumers or prescribers to choose generics, and their market share ...
March 2012
... Ctii tbild bt Continuing o uild on our ro us small-molecule generic pipeline Evolving in new directions beyond gy small-molecule compounds including biosimilars such as retacrit (Epo ...
November 2012
... Ingredient as branded products. At the beginning of the campaign 72% of consumers said they would use a generic medicine and this rose to 77% after the campaign. generic medicines rose 5% as a proportion ...